Granite Investment Partners’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
BG
Granite Investment Partners's CDNA Position: Q2 2022 in Review
Granite Investment Partners sold out of CareDx (CDNA) in Q2 2022, closing a stake of 435,178 shares — an estimated $16.1M sold.
Granite Investment Partners first reported a position in CDNA in Q1 2020 and held it in 9 quarters. The position peaked at $43M in Q2 2021. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.
- Granite Investment Partners reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
- Granite Investment Partners sold 435,178 CareDx shares in Q2 2022, an estimated $16.1M.
- Granite Investment Partners first reported a position in CareDx in Q1 2020 and held it in 9 quarters.
- Granite Investment Partners's CareDx position peaked at $43M in Q2 2021.
- 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.
Based on Granite Investment Partners's 13F filing for Q2 2022, filed 22 Jul 2022.